Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma

The genetic aetiology and the molecular mechanisms that characterize high‐risk neuroblastoma are still little understood. The majority of high‐risk neuroblastoma patients do not take advantage of current induction therapy. So far, one of the main reasons liable for cancer therapeutic failure is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Avitabile, Marianna, Lasorsa, Vito Alessandro, Cantalupo, Sueva, Cardinale, Antonella, Cimmino, Flora, Montella, Annalaura, Capasso, Dalila, Haupt, Riccardo, Amoroso, Loredana, Garaventa, Alberto, Quattrone, Alessandro, Corrias, Maria Valeria, Iolascon, Achille, Capasso, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171401/
https://www.ncbi.nlm.nih.gov/pubmed/32103589
http://dx.doi.org/10.1111/jcmm.15058

Ejemplares similares

Ejemplares similares